nitrites has been researched along with Cardiovascular Stroke in 90 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the protective effects of lycopene on electrocardiographic, hemodynamic, biochemical and apoptotic changes in isoproterenol induced myocardial infarction." | 7.78 | Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study. ( Aman, U; Balaraman, R; Vaibhav, P, 2012) |
| "We examined the effects of chronic oral L-arginine treatment on endothelial and cardiovascular function in rats with heart failure induced by coronary artery ligation." | 7.70 | Effects of L-arginine on endothelial and cardiac function in rats with heart failure. ( Arnold, JM; Arnold, O; Feng, Q; Fortin, AJ; Lu, X, 1999) |
| "Treatment with hesperidin showed a significant increase in tissue nitrite, antioxidant level and reduction in inflammation, arrhythmias and apoptosis." | 5.35 | Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin. ( Balaraman, R; Gandhi, C; Upaganalawar, A, 2009) |
| " The inflammatory response expressed by PTX3 had a significant relationship with age, heart failure, infarct size, impaired flow in the infarct-related artery, and renal function and positively correlated with neopterin, TNF-α, 8-hydroxy-2'-deoxyguanosine, and nitrite/nitrate." | 3.81 | Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress. ( Ganovska, E; Gottwaldova, J; Jarkovsky, J; Kala, P; Kubena, P; Kubkova, L; Littnerova, S; Mebazaa, A; Mueller, C; Parenica, J; Pavkova Goldbergova, M; Poloczek, M; Spinar, J; Tomandl, J; Tomandlova, M, 2015) |
| "To assess the protective effects of lycopene on electrocardiographic, hemodynamic, biochemical and apoptotic changes in isoproterenol induced myocardial infarction." | 3.78 | Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study. ( Aman, U; Balaraman, R; Vaibhav, P, 2012) |
| "This study was designed to evaluate the anti-inflammatory and anti-apoptotic effects of the alcoholic extract of the berries of Crataegus oxyacantha (AEC), a medicinal herb, on isoproterenol-induced myocardial infarction (MI) in a rat model." | 3.78 | Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage. ( Devaraj, SN; Thiruchenduran, M; Vijayan, NA, 2012) |
| "Inhibition of arginase protects from myocardial infarction by a mechanism that is dependent on NOS activity and bioavailability of NO by shifting arginine utilization from arginase towards NOS." | 3.76 | Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. ( Gonon, AT; Jung, C; Lundberg, JO; Pernow, J; Sjöquist, PO, 2010) |
| "We examined the effects of chronic oral L-arginine treatment on endothelial and cardiovascular function in rats with heart failure induced by coronary artery ligation." | 3.70 | Effects of L-arginine on endothelial and cardiac function in rats with heart failure. ( Arnold, JM; Arnold, O; Feng, Q; Fortin, AJ; Lu, X, 1999) |
| " Under same haemodynamic conditions the treatment of angina pectoris consists of long acting nitrites in combination with a betablocking agent having some intrinsic activity." | 3.65 | [Ventricular aneurysm and coronary heart disease. Pathophysiology, differential therapy, and postoperative haemodynamics (author's transl)]. ( Bischoff, K; Johannes, E; Kugler, G, 1975) |
| " A decrease in the production and bioavailability of NO is a hallmark of many major chronic diseases including hypertension, ischaemia-reperfusion injury, atherosclerosis and diabetes." | 2.53 | Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases. ( Lundberg, JO; Omar, SA; Webb, AJ; Weitzberg, E, 2016) |
| "Hyperglycemia is known to inhibit ischemic and anesthetic preconditioning." | 1.36 | Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. ( Gozal, Y; Navot, N; Raphael, J; Zuo, Z, 2010) |
| "Treatment with hesperidin showed a significant increase in tissue nitrite, antioxidant level and reduction in inflammation, arrhythmias and apoptosis." | 1.35 | Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin. ( Balaraman, R; Gandhi, C; Upaganalawar, A, 2009) |
| "Myocardial infarction was associated with lower whole blood nitrite levels (200+/-53 nmol/L for elevated serum CK MB levels vs 432+/-95 nmol/L in the normal CK MB range, p=0." | 1.35 | Serial measurements of whole blood nitrite in an intensive care setting. ( Balzer, J; Heusch, G; Kehmeier, ES; Kelm, M; Kleinbongard, P; Kropp, M; Lauer, T; Lepper, W; Merx, MW; Rassaf, T, 2008) |
| " Moreover, upregulation of NADH oxidase leads to increased presence of superoxide and peroxynitrite and thereby to a reduction of the bioavailability and compensatory effects of NO, as such influencing post-infarction remodelling." | 1.34 | Time-dependent expression pattern of nitric oxide and superoxide after myocardial infarction in rats. ( Berges, A; Timmermans, JP; Van Nassauw, L; Vrints, C, 2007) |
| " Long-term administration (2 mo) of the selective NOS II inhibitor S-methylisothiourea (SMT) to rats with MI significantly improved cardiac function." | 1.31 | Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure. ( Fahas, L; Giaid, A; Hu, F; Saito, T; Shennib, H; Tayara, L, 2002) |
| "Aspirin was administered intravenously (iv) as water-soluble Aspisol, d-lysinmono (acetylsalicylate) (Bayer, Leverkusen, Germany) into an ear vein." | 1.30 | Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin. ( Bing, RJ; Cho, YK; Cohen, AM; Johnson, PE; Kakar, NR; Yamamoto, M; Yamamoto, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (25.56) | 18.7374 |
| 1990's | 5 (5.56) | 18.2507 |
| 2000's | 32 (35.56) | 29.6817 |
| 2010's | 29 (32.22) | 24.3611 |
| 2020's | 1 (1.11) | 2.80 |
| Authors | Studies |
|---|---|
| Koka, S | 1 |
| Xi, L | 1 |
| Kukreja, RC | 1 |
| Gopcevic, K | 1 |
| Rovcanin, B | 1 |
| Kekic, D | 1 |
| Milasinovic, D | 1 |
| Kocic, G | 1 |
| Stojanovic, I | 1 |
| Totzeck, M | 2 |
| Korste, S | 1 |
| Miinalainen, I | 1 |
| Hendgen-Cotta, UB | 3 |
| Rassaf, T | 5 |
| Vishwakarma, VK | 1 |
| Goyal, A | 3 |
| Gupta, JK | 2 |
| Upadhyay, PK | 1 |
| Yadav, HN | 3 |
| Wang, Y | 1 |
| Song, X | 1 |
| Yue, X | 1 |
| Su, H | 1 |
| Gu, Y | 1 |
| Bowman, L | 1 |
| Ding, M | 1 |
| Zou, B | 1 |
| Zhao, J | 1 |
| Lin, X | 1 |
| Yellon, DM | 1 |
| He, Z | 1 |
| Khambata, R | 1 |
| Ahluwalia, A | 1 |
| Davidson, SM | 1 |
| Sharma, AK | 1 |
| Kumar, A | 1 |
| Taneja, G | 1 |
| Nagaich, U | 1 |
| Deep, A | 1 |
| Datusalia, AK | 1 |
| Rajput, SK | 1 |
| Naryzhnaya, NV | 3 |
| Maslov, LN | 3 |
| Tsibulnikov, SY | 2 |
| Ma, H | 1 |
| Lishmanov, YB | 2 |
| Oeltgen, PR | 1 |
| Garlid, K | 1 |
| Inserte, J | 1 |
| Hernando, V | 1 |
| Vilardosa, Ú | 1 |
| Abad, E | 1 |
| Poncelas-Nozal, M | 1 |
| Garcia-Dorado, D | 1 |
| Sobierajski, J | 1 |
| Kelm, M | 3 |
| Aman, U | 1 |
| Vaibhav, P | 1 |
| Balaraman, R | 2 |
| Qipshidze-Kelm, N | 1 |
| Piell, KM | 1 |
| Solinger, JC | 1 |
| Cole, MP | 1 |
| Tomandlova, M | 1 |
| Jarkovsky, J | 1 |
| Tomandl, J | 1 |
| Kubkova, L | 1 |
| Kala, P | 1 |
| Littnerova, S | 1 |
| Gottwaldova, J | 1 |
| Kubena, P | 1 |
| Ganovska, E | 1 |
| Poloczek, M | 1 |
| Spinar, J | 1 |
| Mueller, C | 1 |
| Mebazaa, A | 1 |
| Pavkova Goldbergova, M | 1 |
| Parenica, J | 1 |
| Semwal, BC | 1 |
| Omar, SA | 1 |
| Webb, AJ | 1 |
| Lundberg, JO | 2 |
| Weitzberg, E | 1 |
| Prokudina, ES | 1 |
| Charan, K | 1 |
| Valle Raleigh, J | 1 |
| Mauro, AG | 1 |
| Devarakonda, T | 1 |
| Marchetti, C | 1 |
| He, J | 1 |
| Kim, E | 1 |
| Filippone, S | 1 |
| Das, A | 1 |
| Toldo, S | 1 |
| Abbate, A | 1 |
| Salloum, FN | 1 |
| Gonzalez, FM | 1 |
| Shiva, S | 4 |
| Vincent, PS | 1 |
| Ringwood, LA | 1 |
| Hsu, LY | 1 |
| Hon, YY | 1 |
| Aletras, AH | 1 |
| Cannon, RO | 1 |
| Gladwin, MT | 4 |
| Arai, AE | 1 |
| Merx, MW | 2 |
| Schmitz, J | 1 |
| Becher, S | 1 |
| Klare, JP | 1 |
| Steinhoff, HJ | 1 |
| Goedecke, A | 1 |
| Schrader, J | 1 |
| Sinha, SS | 1 |
| Caimi, G | 1 |
| Montana, M | 1 |
| Calandrino, V | 1 |
| Caruso, M | 1 |
| Carollo, C | 1 |
| Catania, A | 1 |
| Lo Presti, R | 1 |
| Calvert, JW | 2 |
| Lefer, DJ | 2 |
| Tsikas, D | 1 |
| Rossi, R | 1 |
| Gandhi, C | 1 |
| Upaganalawar, A | 1 |
| Jung, C | 1 |
| Gonon, AT | 1 |
| Sjöquist, PO | 1 |
| Pernow, J | 1 |
| Milano, G | 1 |
| Corno, AF | 1 |
| Samaja, M | 1 |
| Morel, S | 1 |
| Vassalli, G | 1 |
| von Segesser, LK | 1 |
| Raphael, J | 1 |
| Gozal, Y | 1 |
| Navot, N | 1 |
| Zuo, Z | 1 |
| Joseph, PM | 1 |
| Di Filippo, C | 1 |
| Monopoli, A | 1 |
| Ongini, E | 1 |
| Perretti, M | 1 |
| D'Amico, M | 1 |
| Kudriashova, MV | 1 |
| Dovgaliuk, IuV | 1 |
| Mishina, LE | 1 |
| Berezin, MV | 1 |
| Grineva, MR | 1 |
| Pakhrova, OA | 1 |
| Mazanko, OE | 1 |
| Akinmoladun, AC | 1 |
| Obuotor, EM | 1 |
| Barthwal, MK | 1 |
| Dikshit, M | 1 |
| Farombi, EO | 1 |
| Wang, E | 1 |
| Feng, Y | 1 |
| Zhang, M | 1 |
| Zou, L | 1 |
| Li, Y | 1 |
| Buys, ES | 1 |
| Huang, P | 1 |
| Brouckaert, P | 1 |
| Chao, W | 1 |
| Vijayan, NA | 1 |
| Thiruchenduran, M | 1 |
| Devaraj, SN | 1 |
| Neye, N | 1 |
| Enigk, F | 1 |
| Habazettl, H | 1 |
| Plesnila, N | 1 |
| Kuppe, H | 1 |
| Kuebler, WM | 1 |
| Ikeda, U | 1 |
| Maeda, Y | 1 |
| Yamamoto, K | 1 |
| Shimada, K | 1 |
| Agata, J | 1 |
| Chao, L | 2 |
| Chao, J | 2 |
| Wood, SP | 1 |
| STREIT, M | 1 |
| TAESCHLER, M | 1 |
| MOMOT, MD | 1 |
| FRAU, G | 1 |
| BERGAMASCO, G | 1 |
| SELJESKOG, EL | 1 |
| HITCHCOCK, CR | 1 |
| GROOVER, ME | 1 |
| HAGLIN, JJ | 1 |
| STROBEL, CJ | 1 |
| WISING, PJ | 1 |
| CHAND, A | 1 |
| GAWELLEK, F | 1 |
| ECKERT, H | 1 |
| SOMERVILLE, W | 1 |
| NORDQVIST, P | 1 |
| VARNAUSKAS, E | 1 |
| Ralay Ranaivo, H | 1 |
| Diebolt, M | 1 |
| Andriantsitohaina, R | 1 |
| Berges, A | 2 |
| Van Nassauw, L | 2 |
| Timmermans, JP | 2 |
| Vrints, C | 2 |
| Zhu, YZ | 1 |
| Chong, CL | 1 |
| Chuah, SC | 1 |
| Huang, SH | 1 |
| Nai, HS | 1 |
| Tong, HT | 1 |
| Whiteman, M | 1 |
| Moore, PK | 1 |
| Jones, SP | 1 |
| Bolli, R | 1 |
| Drapkina, OM | 1 |
| Ivashkin, VT | 1 |
| Wajima, T | 1 |
| Shimizu, S | 1 |
| Hiroi, T | 1 |
| Ishii, M | 1 |
| Kiuchi, Y | 1 |
| Kuralay, F | 1 |
| Altekin, E | 1 |
| Yazlar, AS | 1 |
| Onvural, B | 1 |
| Goldeli, O | 1 |
| Baker, JE | 1 |
| Su, J | 1 |
| Fu, X | 1 |
| Hsu, A | 1 |
| Gross, GJ | 1 |
| Tweddell, JS | 1 |
| Hogg, N | 1 |
| Yao, YY | 1 |
| Yin, H | 1 |
| Shen, B | 1 |
| Bryan, NS | 1 |
| Elrod, JW | 1 |
| Gundewar, S | 1 |
| Ji, SY | 1 |
| Kehmeier, ES | 1 |
| Kropp, M | 1 |
| Kleinbongard, P | 1 |
| Lauer, T | 1 |
| Balzer, J | 1 |
| Heusch, G | 1 |
| Lepper, W | 1 |
| Cía Gómez, P | 1 |
| Akiyama, K | 2 |
| Suzuki, H | 2 |
| Grant, P | 1 |
| Bing, RJ | 4 |
| Kimura, A | 2 |
| Takeyama, Y | 1 |
| Gluckman, TL | 1 |
| Terhakopian, A | 1 |
| Katagiri, T | 1 |
| Suh, KY | 2 |
| Roseto, J | 2 |
| Cohen, AM | 2 |
| Yamamoto, T | 1 |
| Kakar, NR | 1 |
| Yamamoto, M | 1 |
| Johnson, PE | 1 |
| Cho, YK | 1 |
| Feng, Q | 2 |
| Fortin, AJ | 1 |
| Lu, X | 2 |
| Arnold, JM | 2 |
| Arnold, O | 1 |
| Giroux, M | 1 |
| Ruidavets, JB | 1 |
| Ferrières, J | 1 |
| Manukhina, EB | 1 |
| Smirin, BV | 2 |
| Lyamina, NP | 1 |
| Senchikhin, VN | 1 |
| Vanin, AF | 1 |
| Buikema, H | 1 |
| Monnink, SH | 1 |
| Tio, RA | 1 |
| Crijns, HJ | 1 |
| de Zeeuw, D | 1 |
| van Gilst, WH | 1 |
| Yoon, Y | 1 |
| Song, J | 1 |
| Hong, SH | 1 |
| Kim, JQ | 1 |
| Miyamoto, Y | 1 |
| Saito, Y | 1 |
| Nakayama, M | 1 |
| Shimasaki, Y | 1 |
| Yoshimura, T | 1 |
| Yoshimura, M | 1 |
| Harada, M | 1 |
| Kajiyama, N | 1 |
| Kishimoto, I | 1 |
| Kuwahara, K | 1 |
| Hino, J | 1 |
| Ogawa, E | 1 |
| Hamanaka, I | 1 |
| Kamitani, S | 1 |
| Takahashi, N | 1 |
| Kawakami, R | 1 |
| Kangawa, K | 1 |
| Yasue, H | 1 |
| Nakao, K | 1 |
| Jain, AP | 1 |
| Mohan, A | 1 |
| Gupta, OP | 1 |
| Jajoo, UN | 1 |
| Kalantri, SP | 1 |
| Srivastava, LM | 1 |
| Hung, LM | 1 |
| Chen, JK | 1 |
| Lee, RS | 1 |
| Liang, HC | 1 |
| Su, MJ | 1 |
| Jones, DL | 1 |
| Shen, J | 1 |
| Pshennikova, MG | 1 |
| Belkina, LM | 1 |
| Bakhtina, LY | 1 |
| Baida, LA | 1 |
| Malyshev, IY | 1 |
| Saito, T | 1 |
| Hu, F | 1 |
| Tayara, L | 1 |
| Fahas, L | 1 |
| Shennib, H | 1 |
| Giaid, A | 1 |
| Erbel, R | 1 |
| Belz, GG | 1 |
| Johannes, E | 1 |
| Bischoff, K | 1 |
| Kugler, G | 1 |
| Riecker, G | 1 |
| Borghi, E | 1 |
| Roventini, L | 1 |
| Vecce, R | 1 |
| Schembri, S | 1 |
| Maurini, V | 1 |
| Giomi, N | 1 |
| Cantini, R | 1 |
| Rindi, M | 1 |
| Lenzi, R | 1 |
| Barzi, F | 1 |
| Dupuis, B | 1 |
| Vincent, A | 1 |
| Lablanche, JM | 1 |
| França, A | 1 |
| Nogueira Pereira, J | 1 |
| Laires, MJ | 1 |
| Pereira, T | 1 |
| Rabaçal, C | 1 |
| Halpern, MJ | 1 |
| Simões Fernandes, J | 1 |
| Duck, HJ | 1 |
| Trenckmann, H | 1 |
| Fleischmann, HJ | 1 |
| Neugebauer, A | 1 |
| Schauer, J | 1 |
| Popescu, P | 1 |
| Gherasim, L | 1 |
| Lacher, JW | 1 |
| Nager, F | 1 |
| Monroe, RG | 1 |
| Gamble, WJ | 1 |
| LaFarge, CG | 1 |
| Kumar, AE | 1 |
| Stark, J | 1 |
| Sanders, GL | 1 |
| Phornphutkul, C | 1 |
| Davis, M | 1 |
| Likoff, W | 1 |
| Ammermann, EO | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Safety and Efficacy Evaluation of Sodium Nitrite Injection for the Prevention of Ischemia-Reperfusion Injury Associated With Acute Myocardial Infarction.[NCT00924118] | Phase 2 | 30 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
| Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction[NCT05711719] | Phase 2 | 45 participants (Anticipated) | Interventional | 2023-06-16 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Left ventricular infarct size by Magnetic Resonance Imaging (MRI). Calculated percentage of the left ventricular mass by MRI that has undergone infarction. (NCT00924118)
Timeframe: 4-5 days following enrollment
| Intervention | infarct percentage of left ventricle (Mean) |
|---|---|
| Sodium Nitrite | 15.5 |
| Open Control | 24 |
9 reviews available for nitrites and Cardiovascular Stroke
| Article | Year |
|---|---|
Nitrite-Nitric Oxide Signaling and Cardioprotection.
Topics: Animals; Cytoprotection; Humans; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Myocardi | 2017 |
[INVOLVEMENT OF NITRIC OXIDE CYNTHASE IN THE EARLY PHASE OF THE HEART ISCHEMIC PRECONDITIONING].
Topics: Animals; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Isc | 2016 |
[New strategies in cardioprotection during acute myocardial infarction: Impact of hypoxic nitrate-nitrite-NO signaling].
Topics: Animals; Humans; Models, Cardiovascular; Myocardial Infarction; Myocardial Reperfusion Injury; Nitra | 2013 |
Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases.
Topics: Animals; Biological Availability; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Di | 2016 |
Myocardial protection by nitrite: evidence that this reperfusion therapeutic will not be lost in translation.
Topics: Animals; Clinical Trials as Topic; Cytoprotection; Hemoglobins; Humans; Myocardial Infarction; Myoca | 2008 |
Myocardial protection by nitrite.
Topics: Animals; Cytoprotection; Homeostasis; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; | 2009 |
The ubiquitous role of nitric oxide in cardioprotection.
Topics: Animals; Heart; Humans; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Myocardial Infarc | 2006 |
[Beta blockers in ischemic cardiopathy].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Dose-Response Relationship, Drug; Follow-Up S | 1984 |
[Recent aspects on basic drug therapy of acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Allopurinol; Analgesics; Anticoagulants; Aprotinin; Cardiac Glycosides; | 1977 |
81 other studies available for nitrites and Cardiovascular Stroke
| Article | Year |
|---|---|
Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dyslipidemias; Heart; Insulin Resistance; Male; | 2020 |
Gelatinases A and B and Antioxidant Enzyme Activity in the Early Phase of Acute Myocardial Infarction.
Topics: Aged; Antioxidants; Case-Control Studies; Catalase; Gelatinases; Glutathione Peroxidase; Glutathione | 2017 |
S-nitrosation of calpains is associated with cardioprotection in myocardial I/R injury.
Topics: Animals; Calpain; Cell Line; Male; Mice, Inbred C57BL; Mitochondria; Myocardial Infarction; Myocardi | 2017 |
Involvement of atrial natriuretic peptide in abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart.
Topics: Animals; Atrial Natriuretic Factor; Cardiotonic Agents; Creatine Kinase, MB Form; Female; Ischemic P | 2018 |
Protection by nitrite against the ischemic effects induced by acute myocardial infarction in mice.
Topics: Administration, Oral; Animals; Cardiotonic Agents; Disease Models, Animal; Male; Mice; Mice, Inbred | 2017 |
The GTN patch: a simple and effective new approach to cardioprotection?
Topics: Administration, Cutaneous; Animals; Blood Pressure; Disease Models, Animal; Male; Mice, Inbred C57BL | 2018 |
Combined and individual strategy of exercise generated preconditioning and low dose copper nanoparticles serve as superlative approach to ameliorate ISO-induced myocardial infarction in rats.
Topics: Androstadienes; Animals; Cardiotonic Agents; Copper; Creatine Kinase, MB Form; Glycogen Synthase Kin | 2018 |
Role of protein kinase C, PI3 kinase, tyrosine kinases, NO-synthase, KATP channels and MPT pore in the signaling pathway of the cardioprotective effect of chronic continuous hypoxia.
Topics: Animals; Arrhythmias, Cardiac; Cell Hypoxia; Hemodynamics; KATP Channels; Male; Mitochondrial Membra | 2018 |
Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling.
Topics: Animals; Biopterins; Cell Death; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, A | 2013 |
Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study.
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Carotenoids; Caspase 3; Disease Models, Animal | 2012 |
Co-treatment with conjugated linoleic acid and nitrite protects against myocardial infarction.
Topics: Animals; Dynamins; Echocardiography; Heart; Heme Oxygenase-1; Hemodynamics; Linoleic Acids, Conjugat | 2013 |
Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Biomarkers; C-Reactive Protein; Deoxyguanosine; Female; Heart Fai | 2015 |
Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart.
Topics: Animals; Caveolin 1; Creatine Kinase, MB Form; Disease Models, Animal; Female; Heart; In Vitro Techn | 2016 |
[INVOLVEMENT OF NO-SYNTHASE IN THE INFARCT REDUCING EFFECT OF CONTINUOUS CHRONIC NORMOBARTC HYPOXTA].
Topics: Animals; Hypoxia; Ischemic Preconditioning, Myocardial; Isothiuronium; Male; Myocardial Infarction; | 2015 |
Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart.
Topics: Alloxan; Animals; Atrial Natriuretic Factor; Blood Glucose; Diabetes Mellitus, Experimental; Drug Ev | 2016 |
Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
Topics: Animals; Cardiovascular Agents; Caspase 1; Cells, Cultured; Disease Models, Animal; Inflammasomes; M | 2017 |
Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction.
Topics: Animals; Anions; Apoptosis; Cardiotonic Agents; Cytoprotection; Disease Models, Animal; Dogs; Hemogl | 2008 |
Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury.
Topics: Aconitate Hydratase; Animals; Cell Respiration; Cell Survival; Heme; In Vitro Techniques; Male; Mice | 2008 |
Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction.
Topics: Adult; Female; Humans; Inflammation; Male; Myocardial Infarction; Nitrates; Nitric Oxide; Nitrites; | 2008 |
Letter by Tsikas and Rossi regarding article, "Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction".
Topics: Animals; Apoptosis; Cardiotonic Agents; Combined Modality Therapy; Cytoprotection; Dogs; Erythrocyte | 2009 |
Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Arrhythmias, Car | 2009 |
Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.
Topics: Amino Acids; Animals; Arginase; Arginine; Blood Pressure; Enzyme Inhibitors; Heart Rate; Male; Myoca | 2010 |
Daily reoxygenation decreases myocardial injury and improves post-ischaemic recovery after chronic hypoxia.
Topics: Animals; Body Weight; Chronic Disease; Hematocrit; Hemoglobins; Hypoxia; Male; Myocardial Infarction | 2010 |
Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling.
Topics: Anesthetics; Animals; Blood Glucose; Blood Pressure; Creatine Kinase, MB Form; Glucose; Heart; Heart | 2010 |
Response to Bhaskaran et al's "Effects of air pollution on the incidence of myocardial infarction".
Topics: Air Pollution; Humans; Myocardial Infarction; Nitrites; Ozone; Particulate Matter | 2010 |
The cardio-protective properties of Ncx-6550, a nitric oxide donating pravastatin, in the mouse.
Topics: Animals; Cardiotonic Agents; Heme Oxygenase-1; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inh | 2010 |
[Possibilities of correction of rheological properties of the blood and free radical processess in patients with acute myocardial infarction combined with type 2 diabetes mellitus].
Topics: Arrhythmias, Cardiac; Blood Viscosity; Diabetes Mellitus, Type 2; Electrocardiography; Electrocardio | 2010 |
Ramipril-like activity of Spondias mombin linn against no-flow ischemia and isoproterenol-induced cardiotoxicity in rat heart.
Topics: Anacardiaceae; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Catalase; C | 2010 |
Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Echocardiography; Electrocardiography; Guanylate Cyc | 2011 |
Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Catalase; Crataegus; Creatine Kinase; Cyclooxygenase 2 | 2012 |
Inhalation of NO during myocardial ischemia reduces infarct size and improves cardiac function.
Topics: Administration, Inhalation; Animals; Cardiac Output; Cardiotonic Agents; Guanylate Cyclase; Male; Mo | 2012 |
C-Reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes.
Topics: Animals; C-Reactive Protein; Cardiomyopathy, Dilated; Cells, Cultured; Enzyme Inhibitors; Humans; In | 2002 |
Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction.
Topics: Adenoviridae; Animals; Apoptosis; Cell Survival; Disease Models, Animal; Dobutamine; Gene Transfer T | 2002 |
Differentiating diagnoses.
Topics: Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Dissection; Chest Pain; Diagnosis, Dif | 2003 |
[Pharmacodynamic studies on experimental cardiac infarcts in rats].
Topics: Animals; Electrocardiography; Myocardial Infarction; Nitrites; Papaverine; Rats | 1957 |
[Characteristics of cardiovascular reactions to nitroglycerin in patients with myocardial infarct].
Topics: Humans; Myocardial Infarction; Nitrites; Nitroglycerin | 1960 |
[The use of intravenous nitroglycerin in the therapy of coronary disease. Preliminary results].
Topics: Administration, Intravenous; Angina Pectoris; Coronary Disease; Humans; Myocardial Infarction; Nitri | 1962 |
Isosorbide dinitrate during acute coronary occlusion. Effects in the baboon.
Topics: Animals; Coronary Occlusion; Heart; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitrites; P | 1963 |
THE BECK-I OPERATION FOR ANGINA PECTORIS: MEDICAL ASPECTS.
Topics: Angina Pectoris; Cardiac Surgical Procedures; Myocardial Infarction; Nitrites; Rehabilitation; Stati | 1963 |
CORONARY ARTERY DISEASE AND MY DOUBTS.
Topics: Anticoagulants; Arteriosclerosis; Cholesterol; Coronary Artery Disease; Coronary Disease; Dietary Fa | 1964 |
[CATECHOLAMINE EXCRETION AND THE CLINICAL PICTURE IN THE MANAGEMENT OF CARDIAC INFARCTION AND CORONARY INSUFFICIENCY WITH N 3-PHENYLPROPYL -(2) 1, 1-DIPHENYL-PROPYL-(3)-AMINE].
Topics: Biphenyl Compounds; Catecholamines; Coronary Disease; Drug Therapy; Epinephrine; Geriatrics; Infarct | 1964 |
The diagnosis and man agement of coronary disease.
Topics: Angina Pectoris; Anticoagulants; Coronary Disease; Humans; Myocardial Infarction; Nitrites | 1955 |
[Ettriol trinitrate--a new nitrate compound].
Topics: Angina Pectoris; Myocardial Infarction; Nitrates; Nitrites; Nitrogen Oxides | 1960 |
Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide.
Topics: Administration, Oral; Aldehydes; Animals; Blood Pressure; Blotting, Western; Carbachol; Coronary Cir | 2004 |
Role of nitric oxide during coronary endothelial dysfunction after myocardial infarction.
Topics: Adenosine; Amidines; Animals; Benzylamines; Bradykinin; Coronary Circulation; Cytochrome P-450 Enzym | 2005 |
Cardioprotective effects of nitroparacetamol and paracetamol in acute phase of myocardial infarction in experimental rats.
Topics: Acetaminophen; Animals; Capillaries; Cardiotonic Agents; Coronary Vessels; Hemodynamics; Liver; Male | 2006 |
[Nitric oxide and cardiac failure].
Topics: Adult; Cardiac Output, Low; Case-Control Studies; Female; Humans; Leukocytes, Mononuclear; Male; Mid | 2005 |
Reduction of myocardial infarct size by tetrahydrobiopterin: possible involvement of mitochondrial KATP channels activation through nitric oxide production.
Topics: Animals; Anti-Arrhythmia Agents; Arginine; Biopterins; Cyclic GMP; Decanoic Acids; Dose-Response Rel | 2006 |
Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Huma | 2006 |
Time-dependent expression pattern of nitric oxide and superoxide after myocardial infarction in rats.
Topics: Animals; Enzyme Activation; Immunohistochemistry; Kinetics; Male; Myocardial Infarction; Myocardium; | 2007 |
Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels.
Topics: Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; KATP Channels; Male; Myocardial Infar | 2007 |
Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
Topics: Animals; Capillaries; Cardiac Output, Low; Cardiomegaly; Cells, Cultured; Collagen; Coronary Vessels | 2007 |
Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury.
Topics: Administration, Oral; Animals; Dietary Supplements; Drug Evaluation, Preclinical; Heme; Mice; Myocar | 2007 |
Serial measurements of whole blood nitrite in an intensive care setting.
Topics: Aged; Creatine Kinase, MB Form; Critical Illness; Female; Humans; Intensive Care Units; Kidney Funct | 2008 |
Oxidation products of nitric oxide, NO2 and NO3, in plasma after experimental myocardial infarction.
Topics: Analysis of Variance; Animals; Enzyme Induction; Hemodynamics; Linear Models; Male; Myocardial Infar | 1997 |
Production of oxidative products of nitric oxide in infarcted human heart.
Topics: Aged; Aged, 80 and over; Arteries; Coronary Angiography; Coronary Vessels; Diastole; Female; Follow- | 1998 |
Effect of acetylsalicylic acid on nitric oxide production in infarcted heart in situ.
Topics: Animals; Aspirin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Heart; Injections, In | 1998 |
Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Coronary Vessels; Enzyme Activation; Epoprostenol; H | 1999 |
Effects of L-arginine on endothelial and cardiac function in rats with heart failure.
Topics: Animals; Aorta, Thoracic; Arginine; Endothelium, Vascular; Heart; Heart Failure; Hemodynamics; Male; | 1999 |
Atmospheric NO, temperature and ischaemic heart disease. Study in Toulouse and its conurbation.
Topics: Air; Ammonia; France; Humans; Humidity; Myocardial Infarction; Myocardial Ischemia; Nitric Oxide; Ni | 2000 |
Role of nitric oxide in adaptation to hypoxia and adaptive defense.
Topics: Adaptation, Physiological; Animals; Aorta; Blood Pressure; Endothelium, Vascular; Hypertension; Hypo | 2000 |
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; B | 2000 |
Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease.
Topics: Aged; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitrates; Nitric O | 2000 |
Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-->C mutation associated with coronary spastic angina.
Topics: Alleles; Amino Acid Sequence; Angina Pectoris; Animals; Base Sequence; Cell Line; DNA-Binding Protei | 2000 |
Role of oxygen free radicals in causing endothelial damage in acute myocardial infarction.
Topics: Adult; Aged; Coronary Artery Disease; Endothelium, Vascular; Female; Free Radicals; Humans; India; M | 2000 |
Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart.
Topics: Animals; Antioxidants; Free Radical Scavengers; Heart; Hemodynamics; L-Lactate Dehydrogenase; Male; | 2001 |
Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice.
Topics: Animals; Female; Gene Expression Regulation, Enzymologic; Genotype; Heart Ventricles; Hemodynamics; | 2001 |
HSP70 stress proteins, nitric oxide, and resistance of August and Wistar rats to myocardial infarction.
Topics: Animals; Genetic Predisposition to Disease; HSP70 Heat-Shock Proteins; Male; Myocardial Infarction; | 2001 |
Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure.
Topics: Animals; Blotting, Western; Coronary Vessels; Disease Models, Animal; Enzyme Inhibitors; Heart Failu | 2002 |
[Ventricular aneurysm and coronary heart disease. Pathophysiology, differential therapy, and postoperative haemodynamics (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Coronary Disease; Digitalis Glycosides; D | 1975 |
[Coronary disease. Introduction].
Topics: Angiography; Coronary Angiography; Coronary Disease; Creatine Kinase; Glucose; Humans; Insulin; Myoc | 1977 |
[Prolonged use of intravenous nitro derivatives in acute myocardial infarction (AMI)].
Topics: Adult; Aged; Aged, 80 and over; Electrocardiography; Female; Humans; Injections, Intravenous; Male; | 1989 |
[Evaluation of anti-ischemia treatment in man].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Drug | 1987 |
Serum magnesium levels in patients after myocardial infarction or unstable angina treated with nitrites and calcium antagonists.
Topics: Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Drug Therapy, Combination; Follow-Up St | 1985 |
[Drug therapy of ischemic heart disease in ambulatory practice].
Topics: Adrenergic beta-Antagonists; Ambulatory Care; Analgesics; Angina Pectoris; Anticoagulants; Coronary | 1974 |
[Current problems in diagnosis and treatment of angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiography; Anticoagulants; Benzofurans; Coronary Ang | 1972 |
Acquired methemoglobinemia. A case report.
Topics: Aged; Cyanosis; Food Additives; Humans; Male; Methemoglobinemia; Myocardial Infarction; Nitrites | 1973 |
[Conservative therapy of angina pectoris].
Topics: Acute Disease; Amyl Nitrite; Angina Pectoris; Anticoagulants; Coronary Disease; Digitalis Glycosides | 1970 |
The Anrep effect reconsidered.
Topics: Adenosine Triphosphate; Aminophylline; Animals; Blood Flow Velocity; Blood Pressure; Catheterization | 1972 |
Coronary heart disease. New aspects of prevention and treatment.
Topics: Adult; Angina Pectoris; Angiography; Animals; Coronary Disease; Digitalis Glycosides; Dogs; Electroc | 1970 |
A contribution to treatment of angina pectoris with a long acting nitrate (dilcoran 80).
Topics: Angina Pectoris; Humans; Myocardial Infarction; Nitrites | 1967 |